Lotus Pharmaceutical Co., Ltd. (TPE: 1795)
Taiwan
· Delayed Price · Currency is TWD
269.50
-1.50 (-0.55%)
Dec 31, 2024, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 70.20 billion as of January 3, 2025. Its market cap has decreased by -1.69% in one year.
Market Cap
70.20B
Enterprise Value
78.95B
Revenue
17.59B
Ranking
n/a
PE Ratio
16.05
Stock Price
269.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 70.20B, an increase of 664.05%. That is a compound annual growth rate of 21.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 204.69B |
Caliway Biopharmaceuticals | 90.07B |
Bora Pharmaceuticals Co., LTD. | 77.20B |
Oneness Biotech | 40.01B |
Lumosa Therapeutics | 39.86B |
Polaris Group | 34.14B |
Center Laboratories | 31.01B |
Pegavision | 29.64B |